Skip to content

Clinical Study for antioxidant effects of aronia

Double-blind, randomized, placebo-controlled intervention study to evaluate the antioxidant effects and safety of aronia (ABF, Aronia Bioactive Fraction) in healthy voluenteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003013
Enrollment
70
Registered
2018-07-23
Start date
2018-07-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Take a tablet containing Aronia Extraction (ABF) or placebo for 8 weeks. - twice a day, 4tabs(1tab:150mg)/time

Sponsors

JBKLAB
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Person who agrees to participate in this study and has signed written consent 2) Men and women aged 30 to under 60, excluding illiterate people

Exclusion criteria

Exclusion criteria: 1) A person who can not perform a treadmill movement 2) Smokers, alcoholism, drug addiction 3) A good eater (Recommended food score > 36) 4) A BMI of less than 23 kgm2 or greater than 30 kgm2 5) In case of sustained intermediate strength exercise three months prior to the first visit(e.g. three days a week, 30 minutes or more a day). 6) In case of continuous intake of health-function food or herbal medicine within two months of the first visit 7) In case of the following diseases or medical history within the first two years of the visit : - High blood pressure, diabetes, arteriosclerosis, chronic inflammatory diseases (rheumatoid arthritis), heart disease, kidney disease, liver disease, thyroid disease, malignant tumor, mental illness - Other diseases that researchers find inappropriate for this study 8) In case of continuous use of lipid lowering agent, anti-inflammatory, antihypertensive agent, antibiotics, aspirin, hypoglycemic agent, anticoagents Within one month of the first visit 9) If there is an hypersensitivity to test food or its ingredients 10) Participation in any other clinical trial within three months of first visit 11) Pregnant or Breast feeding woman 12) A person who has difficulty using a smartphone 13) Otherwise judged by the investigator to be inappropriate for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Oxidised LDL

Secondary

MeasureTime frame
Antioxidant enzyme activity: erythrocyte Superoxide dismutase, Catalase, GPx activity;Erythrocyte GSH, GSSG, GSSG/GSH ratio;Plasma oxLDL, Malondialdehyde;Plasma IL-6;Plasma lactic acid, serum Lactate dehydrogenase activity;Serum creatine kinase activity

Countries

Korea, Republic of

Contacts

Public ContactKeum-Ran Jeong

Kyung Hee University Hospital

jkr10237@naver.com+82-2-958-2913

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026